Pharmaceutical

Novo Nordisk veteran Maziar Mike Doustdar—who is set to assume the role of CEO on Thursday—will have his work cut out turning things around at the Dan...

Before a single panel kicks off, Fierce Pharma Week already feels different.

Werewolf Therapeutics is transforming its brand awareness and clinical trial recruitment efforts with a new campaign.

The FDA approved Jazz's Modeyso (dordaviprone), which was picked up in the company's $935 million buyout of Chimerix earlier this year, as the first s...

With more than $1 billion in debt due in 2027, Sarepta said it’s “evaluating opportunities to enhance operational efficiency and adjust manufacturing...

Merck pulled off its $10 billion buyout of Verona Pharma last month with little of the wheeling and dealing that typically accompanies a big-money acq...

Garonit Pharmaceutical, an India-based API maker, plans to build a $46.1 million production plant in New York to produce chlorhexidine gluconate, whic...

Aurobindo will shell out $250 million to acquire drugmaker Lannett, shoring up the Indian drugmaker’s footprint in the U.S. amid threats that the Trum...

Vor Bio has handed Dallan Murray a swift return to the workforce. Weeks after being let go by Sarepta Therapeutics, Murray has landed the chief commer...

The FDA has removed a pause in the use of Valneva’s chikungunya vaccine in older adults while tweaking the shot’s label with stricter language.